Julz Pharma is Media and Information Services (B2B) in United States that focus on development services business. Founded in 2016. They cover business area such as biotechnology product, China, advanced technology company, European Union, pharmaceutical product, in-license technology, asset, all aspect, partnering activity, fundraising, due diligence, drug and device development, licensing, M&A negotiation, condition.
Media and Information Services (B2B)
2016
( 8 years old in 2024 )
Development Services
-
1450 Raleigh Road
Suite 200
Chapel Hill, NC 27517-8833
United States
Private
biotechnology productChinaadvanced technology companyEuropean Unionpharmaceutical productin-license technologyassetall aspectpartnering activityfundraisingdue diligencedrug and device developmentlicensingM&A negotiationcondition
* We use standard office opening hours in near Julz Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Julz Pharma is Media and Information Services (B2B) business from United States that founded in 2016 (8 years old in 2024), Julz Pharma business is focusing on Development Services.
Julz Pharma headquarter office and corporate office address is located in 1450 Raleigh Road Suite 200 Chapel Hill, NC 27517-8833 United States.
Julz Pharma was founded in United States.
In 2024, Julz Pharma is currently focus on development services sector.
Above is snippet of Google Trends for "development services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Julz Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
